Nucleic acid amplification (NAA) is one of the most commonly performed molecular biology techniques and is a necessary precursor to a range of methods from gene cloning and site-directed mutagenesis to the quantitative analysis of gene expression. As life science suppliers continue to improve products and services in the nucleic acid amplification market, nucleic acid amplification kits and reagents represent a significant market within the life sciences industry.

Percepta’s 2021 Nucleic Acid Amplification Dashboard™ is the fifth in a series that characterizes the dynamic market for products for nucleic acid amplification experiments. This 2021 Dashboard provides a snapshot of the current market landscape and is compared with data from the 2014 Nucleic Acid Amplification Dashboard where relevant, providing an ongoing story of how the market is adapting to new products, new competitors and new sales and marketing strategies.

The 2021 Nucleic Acid Amplification Dashboard™ was developed from responses to a 29-question survey completed by 523 scientists located in North America and Europe. This Dashboard reveals key market indicators for the nucleic acid amplification market as a whole and for the following techniques representing market sub-segments:

• Standard PCR: PCR with purified DNA template
• Standard RT-PCR: PCR with RNA/cDNA template
• qPCR: Real-time PCR with purified DNA template
• qRT-PCR: Real-time PCR with RNA/cDNA template
• Direct PCR: PCR directly from the unpurified sample without the need for nucleic acid extraction and purification
• Digital PCR: Involves the use of increased number of PCR replicates, partitioning a sample into multiple PCR reactions

The following suppliers were surveyed for this report:

• Agilent Technologies
• BioLine
• Biometra/Analytik Jena
• Bio-Rad
• Bulldog Bio
• Cepheid
• Cytiva/Danaher
• Eppendorf
• Eurofins
• Fluidigm
• GE Healthcare
• Illumina
• Merck / MilliporeSigma
• New England Biolabs
• Promega
• Qiagen
• Quanta Bio
• Roche/Kapa
• TakaraBio
• Bio-Techne
• Thermo Fisher Scientific

5          Executive Summary

7          Dashboard “At A Glance”

10         Market Opportunity Matrix

12         Respondents Qualification

14         Demographics

16         Frequency of Performance: Life Science Techniques

20         Frequency of Performance: Nucleic Acid Amplification Techniques

40         Co-Performance: Nucleic Acid Amplification & Life Science Techniques

43         Throughput, Growth Rate, Price & Monthly Spend

54         Market Size

56         Percentage of Spend with Suppliers (Share of Budget)

75         Customer Satisfaction & Interest in Switching

80         Purchase Decision Factors: Product Features

84         Primary Downstream Application

92         Desired Product Changes

94         Appendix I: Supporting Data

111        Appendix II: Percepta Capabilities and Life Science Dashboards™ Available

Available upon request